AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 2258349 — intervention group
Group type: EXPERIMENTAL
Intervention: Pefloxacin (oral treatment for a mean duration of 13 days)
Number of subjects: 67
Study 2258349 — intervention group
Group type: COMPARATOR
Intervention: Ceftazidime (intravenous treatment for a mean duration of 10 days)
Number of subjects: 67
Study 6248780 — intervention group
Group type: EXPERIMENTAL
Intervention: Dialyzable transfer factor
Number of subjects: 61
Study 6248780 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study 30674315 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal pre-pregnancy BMI and weekly gestational weight gain
Number of subjects: 0
Study 30674315 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly gestational weight gain
Number of subjects: 0
Study 29284542 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical Index
Number of subjects: 53
Study 29284542 — intervention group
Group type: COMPARATOR
Intervention: RETTS‐A
Number of subjects: 53
Study 26440237 — intervention group
Group type: EXPERIMENTAL
Intervention: IV sildenafil
Number of subjects: 0
Study 26440237 — intervention group
Group type: COMPARATOR
Intervention: Control (Group C)
Number of subjects: 0
Study 22819555 — intervention group
Group type: EXPERIMENTAL
Intervention: lycopene-rich diet (224-350 mg lycopene/week)
Number of subjects: 54
Study 22819555 — intervention group
Group type: EXPERIMENTAL
Intervention: lycopene supplement (70 mg lycopene/week)
Number of subjects: 54
Study 22819555 — intervention group
Group type: COMPARATOR
Intervention: control diet (<10 mg lycopene/week)
Number of subjects: 54
Study 21191379 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulfadoxine-pyrimethamine (SP) treatment
Number of subjects: 0
Study 19928658 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative group (patients who underwent surgery)
Number of subjects: 21
Study 19928658 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy volunteers)
Number of subjects: 21
Study 16905573 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous negative extrathoracic pressure (CNEP)
Number of subjects: 133
Study 16905573 — intervention group
Group type: COMPARATOR
Intervention: Standard respiratory management
Number of subjects: 133
Study 15249569 — intervention group
Group type: EXPERIMENTAL
Intervention: NVP only
Number of subjects: 894
Study 15249569 — intervention group
Group type: COMPARATOR
Intervention: NVP plus ZDV
Number of subjects: 894
Study 15249569 — intervention group
Group type: EXPERIMENTAL
Intervention: NVP only (for infants not infected at birth)
Number of subjects: 894
Study 15249569 — intervention group
Group type: COMPARATOR
Intervention: NVP plus ZDV (for infants not infected at birth)
Number of subjects: 894
Study 10837284 — intervention group
Group type: EXPERIMENTAL
Intervention: Folic acid supplementation
Number of subjects: 65
Study 10837284 — intervention group
Group type: EXPERIMENTAL
Intervention: Folic acid-fortified breakfast cereals
Number of subjects: 65
Study 10837284 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased consumption of folate-rich foods
Number of subjects: 65
Study 10837284 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 65
Study 9345249 — intervention group
Group type: EXPERIMENTAL
Intervention: subliminal MIO stimulus
Number of subjects: 74
Study 9345249 — intervention group
Group type: EXPERIMENTAL
Intervention: subliminal stimuli (one of three types)
Number of subjects: 74
Study 9345249 — intervention group
Group type: COMPARATOR
Intervention: control stimulus
Number of subjects: 74
Study 8457814 — intervention group
Group type: EXPERIMENTAL
Intervention: Johnson antishear device
Number of subjects: 10
Study 8457814 — intervention group
Group type: COMPARATOR
Intervention: Standard shin pad
Number of subjects: 10
Study 2938886 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined pill (oral contraceptive)
Number of subjects: 0
Study 2938886 — intervention group
Group type: COMPARATOR
Intervention: Depot-medroxyprogesterone acetate (DMPA)
Number of subjects: 0
Study 2938886 — intervention group
Group type: COMPARATOR
Intervention: Progestin-only pill
Number of subjects: 0
Study 2938886 — intervention group
Group type: COMPARATOR
Intervention: DMPA and progestin-only treatment
Number of subjects: 0
Study 2938886 — intervention group
Group type: COMPARATOR
Intervention: Progestin-only and DMPA groups
Number of subjects: 0
Study 30032176 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyphenol-rich extract from grape and blueberry (PEGB) 600 mg/day for 6 months
Number of subjects: 215
Study 30032176 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 215
Study 30515403 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fat meal ingestion
Number of subjects: 2
Study 27264945 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine 3 µg per kg
Number of subjects: 380
Study 27264945 — intervention group
Group type: COMPARATOR
Intervention: Placebo (equal quantity of saline)
Number of subjects: 380
Study 24889086 — intervention group
Group type: EXPERIMENTAL
Intervention: Best-corrected vision
Number of subjects: 10
Study 24889086 — intervention group
Group type: EXPERIMENTAL
Intervention: +2.00 DS blur
Number of subjects: 10
Study 24889086 — intervention group
Group type: EXPERIMENTAL
Intervention: +3.00 DS blur
Number of subjects: 10
Study 24889086 — intervention group
Group type: EXPERIMENTAL
Intervention: Low contrast targets
Number of subjects: 10
Study 24889086 — intervention group
Group type: COMPARATOR
Intervention: High contrast targets
Number of subjects: 10
Study 22226008 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive glucose-control strategy (aiming for HbA1c ≤6.5%)
Number of subjects: 11140
Study 22226008 — intervention group
Group type: COMPARATOR
Intervention: Standard glucose-control strategy
Number of subjects: 11140
Study 22226008 — intervention group
Group type: COMPARATOR
Intervention: Comparison of intensive vs standard glucose-control
Number of subjects: 11140
Study 22226008 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment combinations including insulin
Number of subjects: 11140
Study 22226008 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment combinations including thiazolidinediones
Number of subjects: 11140
Study 22226008 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment combinations including sulphonylureas
Number of subjects: 11140
Study 20855825 — intervention group
Group type: EXPERIMENTAL
Intervention: Fulvestrant 500 mg
Number of subjects: 736
Study 20855825 — intervention group
Group type: COMPARATOR
Intervention: Fulvestrant 250 mg
Number of subjects: 736
Study 20855825 — intervention group
Group type: EXPERIMENTAL
Intervention: Fulvestrant 500 mg and Fulvestrant 250 mg
Number of subjects: 736
Study 18470404 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 30
Study 18470404 — intervention group
Group type: EXPERIMENTAL
Intervention: Thiopental
Number of subjects: 30
Study 18470404 — intervention group
Group type: COMPARATOR
Intervention: Etomidate
Number of subjects: 30
Study 15844709 — intervention group
Group type: EXPERIMENTAL
Intervention: INF alfacon‐1, 15 microg three times per week, plus ribavirin, 1 g/day
Number of subjects: 128
Study 15844709 — intervention group
Group type: COMPARATOR
Intervention: IFN‐alpha2b, 3 million units three times per week, plus ribavirin, 1 g/day
Number of subjects: 128
Study 12427292 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvoxamine
Number of subjects: 128
Study 12427292 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 128
Study 11022071 — intervention group
Group type: EXPERIMENTAL
Intervention: Dysport 500 U
Number of subjects: 83
Study 11022071 — intervention group
Group type: EXPERIMENTAL
Intervention: Dysport 1000 U
Number of subjects: 83
Study 11022071 — intervention group
Group type: EXPERIMENTAL
Intervention: Dysport 1500 U
Number of subjects: 83
Study 11022071 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 83
Study 8659037 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiation treatment (group 1)
Number of subjects: 122
Study 8659037 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy and estrogens in addition to radiation (group 2)
Number of subjects: 122
Study 8659037 — intervention group
Group type: EXPERIMENTAL
Intervention: Drugs and estrogens (group 3)
Number of subjects: 122
Study 8659037 — intervention group
Group type: EXPERIMENTAL
Intervention: Partial response
Number of subjects: 122
Study 8659037 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphological examination of transrectal prostatic biopsies
Number of subjects: 122
Study 8659037 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term outcomes
Number of subjects: 122
Study 1467075 — intervention group
Group type: EXPERIMENTAL
Intervention: Extradural bupivacaine 10 ml
Number of subjects: 28
Study 1467075 — intervention group
Group type: EXPERIMENTAL
Intervention: Extradural saline 10 ml
Number of subjects: 28
Study 1467075 — intervention group
Group type: COMPARATOR
Intervention: Control (no extradural injection)
Number of subjects: 28
Study 6329021 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine 150 mg orally every 6 hours
Number of subjects: 909
Study 6329021 — intervention group
Group type: COMPARATOR
Intervention: Conventional alkali therapy
Number of subjects: 909
Study 6329021 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine
Number of subjects: 909
Study 6329021 — intervention group
Group type: COMPARATOR
Intervention: Magnesium trisilicate (control)
Number of subjects: 909
Study 30901266 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal cord stimulation
Number of subjects: 0
Study 30901266 — intervention group
Group type: COMPARATOR
Intervention: Control group (non-remitters)
Number of subjects: 0
Study 28874133 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil (20 mg, 3 times daily)
Number of subjects: 103
Study 28874133 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 103
Study 25963037 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive expectations about infrasound prior to first exposure session
Number of subjects: 64
Study 25963037 — intervention group
Group type: COMPARATOR
Intervention: Negative expectations about infrasound prior to first exposure session
Number of subjects: 64
Study 25963037 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive expectations after negative expectations
Number of subjects: 64
Study 23466656 — intervention group
Group type: EXPERIMENTAL
Intervention: ASD
Number of subjects: 92
Study 23466656 — intervention group
Group type: EXPERIMENTAL
Intervention: ADHD
Number of subjects: 92
Study 23466656 — intervention group
Group type: EXPERIMENTAL
Intervention: ASD+ADHD
Number of subjects: 92
Study 23466656 — intervention group
Group type: COMPARATOR
Intervention: TD
Number of subjects: 92
Study 21715446 — intervention group
Group type: EXPERIMENTAL
Intervention: BNP-guided heart failure treatment
Number of subjects: 279
Study 21715446 — intervention group
Group type: COMPARATOR
Intervention: Conventional heart failure treatment
Number of subjects: 279
Study 21715446 — intervention group
Group type: EXPERIMENTAL
Intervention: BNP-guided heart failure treatment (responders)
Number of subjects: 279
Study 21715446 — intervention group
Group type: EXPERIMENTAL
Intervention: BNP-guided heart failure treatment (non-responders)
Number of subjects: 279
Study 19481203 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined spinal-epidural (CSE) analgesia
Number of subjects: 127
Study 19481203 — intervention group
Group type: COMPARATOR
Intervention: Labor epidural (EPI) analgesia
Number of subjects: 127
Study 17056369 — intervention group
Group type: EXPERIMENTAL
Intervention: Clear intraocular lens (VA60BB, HOYA)
Number of subjects: 26
Study 17056369 — intervention group
Group type: EXPERIMENTAL
Intervention: Yellow intraocular lens (YA60BB, HOYA)
Number of subjects: 26
Study 17056369 — intervention group
Group type: COMPARATOR
Intervention: Control group (14 cataractous eyes)
Number of subjects: 26
Study 12762426 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical phenytoin
Number of subjects: 102
Study 12762426 — intervention group
Group type: COMPARATOR
Intervention: EUSOL
Number of subjects: 102
Study 11385064 — intervention group
Group type: COMPARATOR
Intervention: Step II diet (25% fat, 7% saturated fatty acids)
Number of subjects: 20
Study 11385064 — intervention group
Group type: COMPARATOR
Intervention: Olive oil diet (35% fat, 7% saturated fatty acids)
Number of subjects: 20
Study 11385064 — intervention group
Group type: EXPERIMENTAL
Intervention: Average American diet (35% fat, 15% saturated fatty acids)
Number of subjects: 20
Study 11385064 — intervention group
Group type: EXPERIMENTAL
Intervention: Peanut oil diet (35% fat, 7% saturated fatty acids)
Number of subjects: 20
Study 11385064 — intervention group
Group type: EXPERIMENTAL
Intervention: Peanuts plus peanut butter diet (35% fat, 8% saturated fatty acids)
Number of subjects: 20
Study 9054281 — intervention group
Group type: EXPERIMENTAL
Intervention: One drink per day
Number of subjects: 22071
Study 9054281 — intervention group
Group type: COMPARATOR
Intervention: Less than one drink per week
Number of subjects: 22071
Study 7969237 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct response to acetylcholine (ACh) stimulation
Number of subjects: 64
Study 7969237 — intervention group
Group type: COMPARATOR
Intervention: Indirect response via axon reflexes
Number of subjects: 64
Study 7969237 — intervention group
Group type: EXPERIMENTAL
Intervention: Counting sweat droplets by computerized scanning
Number of subjects: 64
Study 7969237 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct response
Number of subjects: 64
Study 7969237 — intervention group
Group type: EXPERIMENTAL
Intervention: Droplet number counts of the direct response
Number of subjects: 64
Study 3573243 — intervention group
Group type: EXPERIMENTAL
Intervention: Tutors offered a short course in critical appraisal of clinical articles
Number of subjects: 4
Study 3573243 — intervention group
Group type: COMPARATOR
Intervention: No special intervention (control)
Number of subjects: 4
Study 2804250 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylprednisolone phosphate (doses between 16 and 1000 mg)
Number of subjects: 6
Study 31308191 — intervention group
Group type: EXPERIMENTAL
Intervention: MDMA-assisted psychotherapy (8-week course, including two therapy sessions with MDMA)
Number of subjects: 7
Study 31308191 — intervention group
Group type: EXPERIMENTAL
Intervention: MDMA-assisted psychotherapy
Number of subjects: 7
Study 28451748 — intervention group
Group type: EXPERIMENTAL
Intervention: BFR-LLRT
Number of subjects: 22
Study 28451748 — intervention group
Group type: EXPERIMENTAL
Intervention: LLRT
Number of subjects: 22
Study 28451748 — intervention group
Group type: COMPARATOR
Intervention: CTR
Number of subjects: 22
Study 28451748 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 22
Study 25861737 — intervention group
Group type: EXPERIMENTAL
Intervention: BI 671800 50 mg bid
Number of subjects: 0
Study 25861737 — intervention group
Group type: EXPERIMENTAL
Intervention: BI 671800 200 mg bid
Number of subjects: 0
Study 25861737 — intervention group
Group type: EXPERIMENTAL
Intervention: BI 671800 400 mg bid
Number of subjects: 0
Study 25861737 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone 220 μg bid
Number of subjects: 0
Study 25861737 — intervention group
Group type: EXPERIMENTAL
Intervention: Montelukast 10 mg qd
Number of subjects: 0
Study 23471101 — intervention group
Group type: EXPERIMENTAL
Intervention: Niccine 40 μg
Number of subjects: 355
Study 23471101 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 355
Study 21660523 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical application of tranexamic acid (2.5 g in 250 ml normal saline)
Number of subjects: 100
Study 18255098 — intervention group
Group type: EXPERIMENTAL
Intervention: Mifepristone (600mg/day for 7 days)
Number of subjects: 39
Study 18255098 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study 16617856 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled corticosteroids (ICS)
Number of subjects: 0
Study 15867406 — intervention group
Group type: EXPERIMENTAL
Intervention: Advanced lipoprotein testing using vertical‐spin density‐gradient ultracentrifugation
Number of subjects: 311
Study 15867406 — intervention group
Group type: COMPARATOR
Intervention: Traditional lipoprotein testing using enzymatic methods
Number of subjects: 311
Study 11280365 — intervention group
Group type: EXPERIMENTAL
Intervention: Bone grafting and implant placement (graft group)
Number of subjects: 43
Study 11280365 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified implant placement with no bone grafting (trial group)
Number of subjects: 43
Study 11280365 — intervention group
Group type: COMPARATOR
Intervention: Optimized complete dentures (no‐implant group)
Number of subjects: 43
Study 9594320 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose urokinase (22,000 IU/kg, total dose not lower than 1.2 million IU)
Number of subjects: 1023
Study 9594320 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose urokinase (30,000 IU/kg, total dose not more than 2.4 million IU)
Number of subjects: 1023
Study 7892972 — intervention group
Group type: EXPERIMENTAL
Intervention: Spontaneous ventilation (SV) with isoflurane 0.97%
Number of subjects: 0
Study 7892972 — intervention group
Group type: COMPARATOR
Intervention: Controlled ventilation (IPPV) with isoflurane 0.60%
Number of subjects: 0
Study 7892972 — intervention group
Group type: EXPERIMENTAL
Intervention: Both SV and IPPV
Number of subjects: 0
Study 3299177 — intervention group
Group type: EXPERIMENTAL
Intervention: Danazol (200 mg/day)
Number of subjects: 14
Study 3299177 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 29882671 — intervention group
Group type: EXPERIMENTAL
Intervention: Microbot with 4.5 μm magnetic microbead under low gradient magnetic field
Number of subjects: 2
Study 29882671 — intervention group
Group type: EXPERIMENTAL
Intervention: Microbot with 2 μm magnetic microbead under low gradient magnetic field
Number of subjects: 2
Study 29882671 — intervention group
Group type: COMPARATOR
Intervention: Microbot in absence of magnetic field
Number of subjects: 2
Study 29882671 — intervention group
Group type: EXPERIMENTAL
Intervention: Microbot under influence of low gradient magnetic field
Number of subjects: 2
Study 27480103 — intervention group
Group type: EXPERIMENTAL
Intervention: Cobimetinib (60 mg once daily for 21 days followed by a 7-day rest period in each 28-day cycle) plus vemurafenib (960 mg twice daily)
Number of subjects: 495
Study 27480103 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus vemurafenib (960 mg twice daily)
Number of subjects: 495
Study 27480103 — intervention group
Group type: EXPERIMENTAL
Intervention: Cobimetinib plus vemurafenib
Number of subjects: 495
Study 27480103 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus vemurafenib
Number of subjects: 495
Study 24740547 — intervention group
Group type: EXPERIMENTAL
Intervention: HPV vaccine (specific dosage and duration not mentioned)
Number of subjects: 6051
Study 22116411 — intervention group
Group type: EXPERIMENTAL
Intervention: Better baseline executive control (Trails B)
Number of subjects: 31
Study 22116411 — intervention group
Group type: EXPERIMENTAL
Intervention: Better visual memory performance (Benton visual retention)
Number of subjects: 31
Study 20093351 — intervention group
Group type: EXPERIMENTAL
Intervention: ECisF (epirubicin 60 mg/m², cisplatin 60 mg/m², 5-FU 200 mg/m² by daily 24-h infusion)
Number of subjects: 349
Study 20093351 — intervention group
Group type: COMPARATOR
Intervention: FEC (5-FU 600 mg/m², epirubicin 60 mg/m², cyclophosphamide 600 mg/m²)
Number of subjects: 349
Study 18505852 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 mg TMC207
Number of subjects: 75
Study 18505852 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg TMC207
Number of subjects: 75
Study 18505852 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 mg TMC207
Number of subjects: 75
Study 18505852 — intervention group
Group type: COMPARATOR
Intervention: 300 mg isoniazid (INH)
Number of subjects: 75
Study 18505852 — intervention group
Group type: COMPARATOR
Intervention: 600 mg rifampin (RIF)
Number of subjects: 75
Study 15920220 — intervention group
Group type: EXPERIMENTAL
Intervention: Ondansetron 4 mg orally the evening before surgery and 4 mg IV 15 min before subarachnoid anesthesia
Number of subjects: 54
Study 15920220 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study 15920220 — intervention group
Group type: EXPERIMENTAL
Intervention: Ondansetron
Number of subjects: 54
Study 12933457 — intervention group
Group type: EXPERIMENTAL
Intervention: Gadobenate dimeglumine at 0.05, 0.1, or 0.2 mmol/kg of body weight
Number of subjects: 189
Study 12933457 — intervention group
Group type: EXPERIMENTAL
Intervention: Gadobenate dimeglumine at 0.1 mmol/kg
Number of subjects: 189
Study 12933457 — intervention group
Group type: COMPARATOR
Intervention: Gadopentetate dimeglumine at 0.1 mmol/kg
Number of subjects: 189
Study 12933457 — intervention group
Group type: EXPERIMENTAL
Intervention: Gadobenate dimeglumine at 0.05 and 0.2 mmol/kg
Number of subjects: 189
Study 11376235 — intervention group
Group type: EXPERIMENTAL
Intervention: Contact group (received at least four letters per year for five years)
Number of subjects: 843
Study 11376235 — intervention group
Group type: COMPARATOR
Intervention: Control group (received no further contact)
Number of subjects: 843
Study 9426097 — intervention group
Group type: EXPERIMENTAL
Intervention: Zopiclone (7.5 mg)
Number of subjects: 8
Study 9426097 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 8115316 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrendipine (20 mg daily for 1 month)
Number of subjects: 20
Study 2960694 — intervention group
Group type: EXPERIMENTAL
Intervention: Thromboxane receptor antagonist BM 13.177 and thromboxane synthase inhibitor dazoxiben
Number of subjects: 25
Study 2960694 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose aspirin
Number of subjects: 25
Study 30256656 — intervention group
Group type: EXPERIMENTAL
Intervention: Average prenatal carbon monoxide exposure (per 1 ppm increase)
Number of subjects: 384
Study 30256656 — intervention group
Group type: EXPERIMENTAL
Intervention: Average prenatal carbon monoxide exposure (per 1 ppm increase) in girls
Number of subjects: 384
Study 30256656 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased respiratory rate at age 30 days
Number of subjects: 384
Study 27532367 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Therapy (CT)
Number of subjects: 75
Study 27532367 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure Therapy (ET)
Number of subjects: 75
Study 25577464 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic excision of ovarian endometrioma (first surgery group)
Number of subjects: 28